How many acquisitions has Scantox made so far?

Scantox has completed 4 acquisitions so far.

List of 4 Acquisitions by Scantox (Oct 2026)

Q: Which is Scantox's latest acquisition?

Scantox's most recent acquisition is Gentronix, a Providr of in-vitro and in-vivo genetic toxicology screening services, acquired in September 2024.

Scantox has made a total of 4 acquisitions. These activities focused exclusively on the Biopharma Outsourcing sector across Sweden and United Kingdom. Activity peaked in 2022 with 2 acquisitions, followed by 1 acquisition in each of 2023 and 2024. The average number of acquisitions per year for the 2020–2025 period is 0.8, with 0 acquisitions completed during the current calendar year. The most recent acquisition is Gentronix, an Alderley Edge-based provider of in-vitro and in-vivo genetic toxicology screening services founded in 1999, which was finalized in September 2024.

Here's the year on year acquisition history of Scantox:

Number of Total Acquisitions

Year	# Acquisitions
2024	1
2023	1
2022	2

View all Acquisitions by Scantox

Recent acquisitions by Scantox

Scantox's most recent acquisition - Gentronix is a Providr of in-vitro and in-vivo genetic toxicology screening services, founded in 1999 and located in Alderley Edge. Scantox acquired it in September 2024 for a price of $*****.

Here is the list of all acquisitions by Scantox sorted by the latest acquisition date:

Acquired on	Acquired Company	Acquisition Price	Facilitators	Stake Acquired	Acquisition Multiple
Sep 09, 2024	Gentronix	vbdh	gcaj	87	907
Aug 31, 2023	Q&Q Labs	ffud	wvtz	60	205
Sep 01, 2022	Timeline Bioresearch	mnqd	cgxt	26	633

View the full list of acquisitions

View all Acquisitions by Scantox

Acquisitions by Scantox

List of Scantox's Acquisitions

Recent acquisitions by Scantox

FAQs about Acquisitions by Scantox